Retraction

Berberine alleviates amyloid beta-induced injury in Alzheimer’s disease by miR-107/ZNF217

Paper Information

Record ID:
25451
Publication Date:
August 13, 2019
Retraction Date:
January 26, 2021 (4.8 years years ago)
Article Type:
Publisher:
Royal Society of Chemistry (RSC)
Open Access:
Yes
PubMed ID:
Not indexed in PubMed
Retraction PubMed ID:
Not indexed in PubMed

Citations (5)

5
Total Citations
3
Post-Retraction
(60.0%)
1
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
3 Within 1 year
0 After 2+ years
363 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Progress in the development of naturally derived active metabolites‐based drugs: Potential therapeutics for Alzheimer's disease
Renuka Mani, Ahmed Sha Sulthana, Ganesan Muthusamy et al. (4 authors)
Biotechnology and Applied Biochemistry
Published: Jan 2022
5 citations
363 days after retraction
Treatment of Parkinson's disease in Zebrafish model with a berberine derivative capable of crossing blood brain barrier, targeting mitochondria, and convenient for bioimaging experiments
Lizhen Wang, Wenlong Sheng, Zhaoshun Tan et al. (10 authors)
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology
Published: Jul 2021
28 citations
186 days after retraction
n-Butylidenephthalide Modulates Autophagy to Ameliorate Neuropathological Progress of Spinocerebellar Ataxia Type 3 through mTOR Pathway
Jui-Hao Lee, Si-Yin Lin, Jen‐Wei Liu et al. (6 authors)
International Journal of Molecular Sciences Open Access
Published: Jun 2021
24 citations
138 days after retraction
Berberine attenuates Aβ42-induced neuronal damage through regulating circHDAC9/miR-142-5p axis in human neuronal cells
Nan Zhang, Yiwen Gao, Shaoli Yu et al. (5 authors)
Life Sciences
Published: Apr 2020
60 citations
297 days before retraction
Quick Stats
Total Citations: 6
Years Since Retraction: 4.8 years
Open Access: Yes
Last Checked: Jul 24, 2025